Primum non nocere, safety of continuous renal replacement therapy
- 1 December 2007
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Critical Care
- Vol. 13 (6) , 635-637
Abstract
To highlight selected adverse effects of continuous renal replacement therapy and to suggest measures for reducing harm. Adverse effects of continuous renal replacement therapy are related to bioincompatibility, bleeding, metabolic consequences, loss of heat, vascular access and human error. Bioincompatibility initiates coagulation and inflammation. Use of membranes with high pore size permits direct removal of the locally formed inflammatory mediators. Regional anticoagulation with citrate reduces the risk of bleeding and abolishes polymorphonuclear and platelet degranulation in the filter. Continuous renal replacement therapy is associated with increased losses of amino acids and the water-soluble vitamins carnitine and selenium. Compared to bicarbonate, lactate-buffered fluids may increase energy needs and glucose intolerance. Patients on continuous renal replacement therapy may lose heat. Several measures can be considered to improve safety of continuous renal replacement therapy. Among these are the use of membranes with high pore size, implementation of citrate to reduce bleeding and bioincompatibility, supplementation of water-soluble vitamins and selenium to increase antioxidant defense, use of bicarbonate-buffered solutions in the most critically ill, and prevention of loss of heat. Last but not least, improvement of safety needs continuous training of staff for better understanding of the method.Keywords
This publication has 28 references indexed in Scilit:
- Beyond the platelet count: Heparin antibodies as independent risk predictorsAmerican Heart Journal, 2007
- Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failureKidney International, 2006
- The future of hemodialysis membranesKidney International, 2006
- Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen speciesJournal of Biomedical Materials Research Part A, 2006
- Myeloperoxidase as a Marker of Hemodialysis Biocompatibility and Oxidative Stress: The Underestimated Modifying Effects of HeparinAmerican Journal of Kidney Diseases, 2006
- Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patientsKidney International, 2005
- Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytesBiomaterials, 2004
- Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients*Critical Care Medicine, 2002
- Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trialNephrology Dialysis Transplantation, 2001
- Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysisKidney International, 1999